Chronic kidney diseases: Common and harmful, but also preventable and treatable;Doença renal crônica: Frequente e grave, mas também prevenível e tratável

Revista da Associacao Medica Brasileira

Volumn 56, Issue 2, 2010, Pages 248-253

  Bastos, Marcus Gomes ^a   Bregman, Rachel ^b   Kirsztajn, Gianna Mastroianni ^c  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Albuminuria; Anemia; Diabetes mellitus; Glomerular filtration rate; Kidney diseases; Proteinuria

Indexed keywords

EID: 77953626689     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0104-42302010000200028     Document Type: Review

References (36)

1. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39(Suppl 2):S1-S246.
2. Sesso R, Lopes, AA, Thomé AS, Bevilacqua, JL, Romão Junior JE, Lugon JR. Elatório do Censo Brasileiro de Diálise, 2008 Relatório do Censo Brasileiro de Diálise, 2008 J Bras Nefrol. 2008;30:233-8.
3. Diretrizes Brasileiras de Doença Renal Crônica. J Bras Nefrol. 2004;26(Supl 1):S1-S49.
4. The National Collaborating Centre for Chronic Conditions. Chronic kidney disease. National clinical guideline for early identification and management in adults in primary and secondary care. Available from: http://www.rcplondon.ac.uk.
5. Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, et al. Guidelines for the management of chronic diseases. CMAJ. 2008;179:1154-62. Available from: http://www.cmaj.ca/cgi/content/full/179/11/1154/DC1.
6. Davies DF, Shock NW. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest. 1950;29:496-507.
7. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc.1985;33:278-85.
8. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol.1976;31:155-63.
9. Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, Polak JF, et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA 1998; 279:585-92.
10. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int. 2002;62:997-1004.
11. Manjunath G, Tighioaurt H, Coresh J, Macleod B, Salem DN, Griffith JL, et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 2003;63:1121-9.
12. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1-12.
13. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron.1976;16:31-41.
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med.1999;130:461-70.
15. Nóbrega AM, Gomes CP, Lemos CC, Bregman R. Is it possible to use modification of diet in renal disease (MDRD) equation in a Brazilian population? J Nephrol. 2006;19:196-9.
16. Bastos RMR, Bastos MG. Tabela de cálculo imediato de filtração glomerular. J Bras Nefrol. 2005;27:40-42.
17. Iseki K. Chronic kidney disease in Japan from early predictions to current facts. Nephron Clin Pract. 2008;110:268-72.
18. Culleton B. Introduction to the Canadian Clinical Practice Guidelines. J Am Soc Nephrol. 2006;17:S1-3.
19. Palmer BF. Renal dysfunction complicating the treatment of hyperensio. N Engl J Med. 2002;347:1256-61.
20. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med. 1998;339:1448-56.
21. Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, Jong PE, et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient level meta-analysis. Ann Intern Med. 2003;139:244-52.
22. Vaziri ND. Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease? Nature Clin Pract Nephrol. 2008;4:436-45.
23. Nangaku M, Eckardt KU. Pathogenesis of renal anemia. Semin Nephrol. 2006; 26:261-8.
24. Post JB, Wilkes BM, Michelis MF. Iron deficiency in patients with chronic kidney disease: potential role for intravenous iron therapy independent of erythropoietin. Int Urol Nephrol. 2006;38:719-23.
25. National Kidney Foundation: KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of hemoglobin target. Am J Kidney Dis. 2007;50:471-530.
26. Diretriz para o Tratamento da Anemia no Paciente com Doença Renal Crônica. J Bras Nefrol. 2007;29(Suppl 4):1-32.
27. Novaka JE, Szczech LA. Triumph and tragedy: anemia management in chronic kidney disease. Cur Opin Nephrol Hypertens. 2008;17:580-8.
28. K/DOQI Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease. Am J Kidney Dis. 2003;41(Suppl 3):S39-S58.
29. Alpern RJ, Sakhaee K. The clinical spectrum of chronic metabolic acidosis: homeostatic mechanisms produce significant morbidity. Am J Kidney Dis. 1997;29:291-302.
30. Oh MS. New perspectives on acid-base balance. Semin Dial. 2000;13:212-219.
31. Brito-Ashurst I, Varagunum M, Raftery MJ, Yoqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol. 2009;20:2075-2084.
32. Excerpts From the United States Renal Data System 2008 Annual Data Report Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 2009;53(Suppl 1):S1-S374.
33. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, The Diabetes Control and Complication Trial Research Group. N Engl J Med. 1993;329:977-86.
34. Cooper M. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet. 1998;352:213-9.
35. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2003;26(Suppl 1):S33-50.
36. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49(Suppl 2):S1-S182.